Trial Details

Not recruiting
Basic Information
Clinical ID c3226
Identifier NCT01410435
Trial Title An Open-label, Multi-Centre, Non-Randomised Extension Study to Assess the Ability to Maintain a Stable Haemoglobin and to Assess Safety of Iron Isomaltoside 1000 (Monofer) in Subjects With Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Disease;Anaemia
Interventions Drug: Monofer
Participant Information
Sponsor Pharmacosmos A/S
City -
Country/Region Austria;Hungary
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE3
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -